KANGHUA BIOLOGICAL(SZ:300841) Zhong Guo Zhi Liang Xin Wen Wang·2025-10-24 03:11Core Points - The article discusses the unconditional approval of several business concentration cases during the period from October 13 to October 19, 2025 [2] Group 1: Business Concentration Cases - Case 1: Yintuo Fund Management Co., Ltd. acquired equity in Fujita Corporation, approved on October 13, 2025 [2] - Case 2: Anhui Jiangkong Chuangfu Private Fund Management Co., Ltd. and Henan Asset Fund Management Co., Ltd. established a new enterprise, approved on October 14, 2025 [2] - Case 3: Shanghai Shansi Capital Management Co., Ltd. and Shanghai Lubu Ka Enterprise Management Consulting Partnership (Limited Partnership) acquired equity in Chengdu Kanghua Biological Products Co., Ltd., approved on October 14, 2025 [2] - Case 4: Wanhuah Chemical Group Battery Technology Co., Ltd. and Tongling Chemical Group Xinqiao Mining Co., Ltd. established a new enterprise, approved on October 14, 2025 [2]